FDA/CBER - Privigen Product Approval Information
26 Jul 2007 ... CBER - Privigen Product Approval Information. ... Tradename: Privigen Manufacturer: CSL Behring AG, License #1766 ...
http://www.fda.gov/Cber/products/privigen.htm...
|
FDA Approvals: EvaMist and Privigen
9 Aug 2007 ... The FDA has approved a metered-dose estradiol transdermal spray (EvaMist) and immune globulin intravenous (human) 10% liquid (Privigen).
http://www.medscape.com/viewarticle/561167...
|
Immune Globulin Intravenous (Human), 10% Liquid (Privigen ...
patients receiving IGIV products containing sucrose. Privigen. ™. does not. contain sucrose. ... Aseptic meningitis syndrome has been reported with Privigen
...
http://www.fda.gov/Cber/label/privigenLB.pdf...
|
...
|
...
|
Safety and Efficacy of Privigen(R), a Novel 10% Li...[J Clin ...
CONCLUSION: Privigen(R) is well tolerated and effective for the treatment of primary immunodeficiency. PMID: 18814020 [PubMed - as supplied by publisher] ...
http://www.ncbi.nlm.nih.gov/pubmed/18814020...
|
CSL Behring Press Releases and Archive
Data Published in Journal of Clinical Immunology Show Privigen™ Demonstrates Effectiveness and Tolerability in Patients with Primary Immunodeficiencies ...
http://www.csl.com.au/s1/cs/enco/1151517263302/news/12214871...
|
CSL Behring Release: Data Published in Journal of Clinical ...
CSL Behring Release: Data Published in Journal of Clinical Immunology Show Privigen(TM) Demonstrates Effectiveness and Tolerability in Patients with
Primary ...
http://www.biospace.com/news_story.aspx?NewsEntityId=111016...
|
Month 00, 0000
20 Feb 2008 ... adult women through to age 45 and 9-26 year old males. Privigen. ®. On 27 July 2007, the US FDA granted marketing approval for Privigen ...
http://www.csl.com.au/docs/358/504/1H08%20ASX%20release%20FI...
|
CMS Manual System
Inj IVIG Privigen 500 mg. INJECTION, IMMUNE GLOBULIN. (PRIVIGEN), INTRAVENOUS,. NON-LYOPHILIZED (E.G.,. LIQUID), 500 MG ...
http://www.cms.hhs.gov/transmittals/downloads/R1492CP.pdf...
|
